Evidence map›Paper›PMID 41405204›Full record

ArticlemSystems2026

Molecular characterization of a clinical ST145

Hao Liu, Chao Yan, Sibo Wang, Juntian Jiang, Meiling Jiao, Fupin Hu, Xuesong Xu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSystems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hao Liu *Department of Laboratory Medicine, China-Japan Union Hospital of Jilin University, Changchun, China.ORCID 0009-0008-3681-1813
Chao Yan *Department of Laboratory Medicine, China-Japan Union Hospital of Jilin University, Changchun, China.
Sibo WangDepartment of Laboratory Medicine, China-Japan Union Hospital of Jilin University, Changchun, China.
Juntian JiangDepartment of Laboratory Medicine, China-Japan Union Hospital of Jilin University, Changchun, China.
Meiling JiaoDepartment of Laboratory Medicine, China-Japan Union Hospital of Jilin University, Changchun, China.
Fupin HuInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.ORCID 0000-0002-4493-0619
Xuesong XuDepartment of Laboratory Medicine, China-Japan Union Hospital of Jilin University, Changchun, China.ORCID 0000-0002-9288-5170

Funding

Department of Science and Technology of Jilin Province YDZJ202402064CXJDNational Natural Science Foundation of China 82172311
6 · The paper itself

Abstract

The objective of this study was to investigate the antimicrobial resistance phenotype and genetic characteristics of a clinical ST145 IMPORTANCE: Carbapenem-resistant

Indexed as

Bacterial Proteinsbeta-LactamasesKlebsiella InfectionsKlebsiella oxytocaAnti-Bacterial AgentsCarbapenemsDrug Resistance, Multiple, BacterialGenome, BacterialHumansMicrobial Sensitivity TestsPhylogenyPlasmidsPolymorphism, Single NucleotideWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase KPC-2beta-LactamasescarbapenemaseCarbapenemsblaIMP-96blaKPC-2carbapenemaseKlebsiella oxytoca

Identifiers

PMID41405204
PMCPMC12817940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.